Kyung Dong Pharmaceutical Co., Ltd. Stock: price and insider trades · South Korea
경동제약
2 insiders bought €19k of shares over the last 90 days, the latest by 류덕희, filed 30 Oct 2026.
Who traded when
BuySaleSince the insiders bought
- -2.1%Entry ₩4,955 · Close 30 Oct 2026 ₩4,850
- -1.1%Entry ₩4,905 · Close 30 Oct 2026 ₩4,850
- -4.7%Entry ₩6,130 · Close at T+365 ₩5,840
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 3,400 sharesShareKRXDART:20261030000192Canonical exit: 28 Jan 2027 (T+90)
- Other0DART
- Other0DART
- Other0DART
- 2,442 sharesShareKRXDART:20260818000143Canonical exit: 16 Nov 2026 (T+90)
- 2,700 sharesShareKRXDART:20260714000125Canonical exit: 12 Oct 2026 (T+90)
- 299,950 sharesShareKRXDART:20260710000180
- 1,649 sharesKRXDART:20260710000187Canonical exit: 8 Oct 2026 (T+90)
- 1,499 sharesShareKRXDART:20260609000236Canonical exit: 7 Sept 2026 (T+90)
- 72,016 sharesKRXDART:20260403003542Canonical exit: 28 Jun 2026 (T+90)
- 1,000 shares@ ₩5,970.000.0039% mcap100.0% of flowShareKRXDART:20260304001083Canonical exit: 27 May 2026 (T+90)
- 2,810 sharesShareKRXDART:20260127000155Canonical exit: 27 Apr 2026 (T+90)
- 5,010 sharesShareKRXDART:20251104000177Canonical exit: 2 Feb 2026 (T+90)
- ●Executives0DART
- 9,900 sharesShareKRXDART:20250702000429Canonical exit: 30 Sept 2025 (T+90)
- 7,000 sharesShareKRXDART:20250509000457Canonical exit: 7 Aug 2025 (T+90)
- 94,668 sharesKRXDART:20250131000350Canonical exit: 21 Apr 2025 (T+90)
- 9,800 sharesKRXDART:20250124000701Canonical exit: 25 Nov 2024 (T+90)
- 68,589 sharesKRXDART:20250124000694Canonical exit: 8 Sept 2024 (T+90)
- 59,500 sharesKRXDART:20250124000662Canonical exit: 27 Jun 2024 (T+90)
- 300 sharesShareKRXDART:20250106000301Canonical exit: 6 Apr 2025 (T+90)
- 10,300 sharesShareKRXDART:20241216000119Canonical exit: 16 Mar 2025 (T+90)
- 2,500 sharesShareKRXDART:20241119000118Canonical exit: 17 Feb 2025 (T+90)
- 59,500 sharesKRXDART:20240827000536Canonical exit: 25 Nov 2024 (T+90)
25 of 73 declarations
About Kyung Dong Pharmaceutical Co., Ltd.
Nearly all the flow at 경동제약 (Kyung Dong Pharmaceutical Co., Ltd.) is buying: 63 purchases against a single sale, or 98% purchases among open-market trades. This South Korean health care company, valued at KRW 146.8 billion, has 68 filings from February 19, 2021 to August 18, 2026.
Two executives sign nearly all of them. 류덕희, filed as 명예회장, has 34 filings, all purchases; 류 기 성 (대표이사) has 28, including 26 purchases and 1 sale. Three purchases carry an amount: EUR 63,416 on January 5, 2024, EUR 13,268 on January 11, 2024 and EUR 3,540 on February 26, 2026, which makes EUR 80,224 in total. On July 10 and July 14, 2026, 2 filers bought.
Read moreShow less
Yearly volume runs from 18 filings in 2021 down to 8 in both 2023 and 2026. The last twelve months hold 9, of which 8 purchases. For 46 purchases a 90-day result is stored: a median of minus 1.4%, with 41% of results positive, recorded past results and not a forecast. The median publication delay is 6 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
